Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1990;16:581-586

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasunari, K.
Right arrow Articles by Takeda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasunari, K.
Right arrow Articles by Takeda, T.

Hypertension, Vol 16, 581-586, Copyright © 1990 by American Heart Association


ARTICLES

Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle

K Yasunari, M Kohno, K Murakawa, K Yokokawa and T Takeda
First Department of Internal Medicine, Osaka City University Medical School, Japan.

The effect of glucocorticoids on the atrial natriuretic factor (ANF)- mediated formation of cyclic guanosine monophosphate (cGMP) by intact vascular smooth muscle cells (VSMC) was studied in rats. Cultured VSMC were obtained from the renal arteries of 14-week-old Wistar rats by the explant method. Micromolar concentrations of dexamethasone, given as pretreatment for 48 hours, suppressed the ANF-mediated response. The dexamethasone-induced suppression was detectable at 6 hours and reached a maximum 24 hours after administration in a dose-dependent manner. Inhibitors of protein synthesis blocked this effect of the glucocorticoid. The basal activity of guanylate cyclase in the dexamethasone-treated cells was lower than in the control cells. Other steroids having glucocorticoid action mimicked this suppression of the ANF-mediated response. This suppression was blocked by a glucocorticoid receptor antagonist. The results suggest that glucocorticoids suppress ANF-mediated cGMP formation by VSMC through glucocorticoid type II receptors and the induction of protein synthesis. Suppression of the ANF-mediated response may play a role in glucocorticoid-induced hypertension.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Sala, B. Ambrosi, and A. Morganti
Blunted Vascular and Renal Effects of Exogenous Atrial Natriuretic Peptide in Patients with Cushing's Disease
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1957 - 1961.
[Abstract] [Full Text]


Home page
International Journal of ToxicologyHome page
J. E. A. Leakey, J. E. Seng, C. R. Barnas, V. M. Baker, and R. W. Hart
A Mechanistic Basis for the Beneficial Effects of Caloric Restriction On Longevity and Disease: Consequences for the Interpretation of Rodent Toxicity Studies
International Journal of Toxicology, January 1, 1998; 17(2_suppl): 5 - 56.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Yasunari, M. Kohno, T. Hasuma, T. Horio, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa
Dopamine as a Novel Antimigration and Antiproliferative Factor of Vascular Smooth Muscle Cells Through Dopamine D1-Like Receptors
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3164 - 3173.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Nuglozeh, M. Mbikay, D. J. Stewart, and L. Legault
Gene expression of natriuretic peptide receptors in rats with DOCA-salt hypertension
Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1427 - C1434.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. W. Zlock, L. Cao, J. Wu, and D. G. Gardner
Thrombin Inhibits Atrial Natriuretic Peptide Receptor Activity in Cultured Bovine Endothelial Cells
Hypertension, January 1, 1997; 29(1): 83 - 90.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa
Dopamine D1-Like Receptor Stimulation Inhibits Hypertrophy Induced by Platelet-Derived Growth Factor in Cultured Rat Renal Vascular Smooth Muscle Cells
Hypertension, January 1, 1997; 29(1): 350 - 354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, T. Horio, and J. Yoshikawa
Possible Involvement of Phospholipase D and Protein Kinase C in Vascular Growth Induced by Elevated Glucose Concentration
Hypertension, August 1, 1996; 28(2): 159 - 168.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, T. Horio, and J. Yoshikawa
Aldose Reductase Inhibitor Prevents Hyperproliferation and Hypertrophy of Cultured Rat Vascular Smooth Muscle Cells Induced by High Glucose
Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2207 - 2212.
[Abstract] [Full Text]